Inhibitors of Serine Proteases, Particularly HCV NS3-NS4A Protease

Details for Australian Patent Application No. 2012202576 (hide)

Owner Vertex Pharmaceuticals, Incorporated

Inventors Farmer, Luc J.; Perni, Robert B.; Bhisetti, Govinda Rao; Wilson, Keith P.

Agent Cullens

Pub. Number AU-A-2012202576

Parent 2011203054

Filing date 2 May 2012

Wipo publication date 24 May 2012

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/401 (2006.01) - Proline

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/425 (2006.01) - Thiazoles

A61K 31/4965 (2006.01) - Non-condensed pyrazines

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

17 May 2012 Complete Application Filed

24 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202576

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202577-Apparatus and method for using effervescent tablets for cosmetic care

2012202575-Treatment for Multiple Sclerosis